Litcius/Paper detail

Lancing Drug Reservoirs into Subcutaneous Fat to Combat Obesity and Associated Metabolic Diseases

Aung Than, Phan Khanh Duong, Ping Zan, Junjie Liu, Melvin Khee‐Shing Leow, Peng Chen

2020Small16 citationsDOI

Abstract

Obesity is a serious epidemic health problem that can cause many other diseases including type 2 diabetes and cardiovascular diseases. Current approaches to combat obesity suffer from low effectiveness and adverse side effects. Here, a new self-administrable and minimally invasive transdermal drug delivery strategy for home-based long-term treatment of obesity and other diseases is developed. Specifically, ultrathin, core-shelled, and lance-shaped polymeric drug reservoirs (micro-lances [MLs]) are readily fabricated by a thermal pressing molding method and totally implanted into subcutaneous fat by lancing through the skin. Using a diet-induced obese mouse model, it is shown that the development of obesity and associated metabolic disorders is effectively inhibited by applying therapeutic core-shelled MLs once every 2 weeks. The outstanding therapeutic effects are attributable to highly localized and biphasic drug release, as well as combination therapy based on browning transformation of white fat and enhanced insulin sensitivity.

Topics & Concepts

ObesityTransdermalMedicineDrugDiabetes mellitusAdverse effectSubcutaneous fatPharmacologyInternal medicineEndocrinologyAdipose tissueAdvancements in Transdermal Drug DeliveryAdipose Tissue and MetabolismLipid Membrane Structure and Behavior
Lancing Drug Reservoirs into Subcutaneous Fat to Combat Obesity and Associated Metabolic Diseases | Litcius